Eva Golunski

15 papers receiving 557 citations

Peers

Eva Golunski
Comparison fields: 5 of 71
  • Molecular Biology 261
  • Pulmonary and Respiratory Medicine 227
  • Biomedical Engineering 97
  • Biomaterials 81
  • Oncology 78
Replace Susanne Koling with:
Susanne Koling Germany
Jeffrey L. Schaal United States
María Merino Spain
Feifei Song China
Xiuhua Pan China
Ken Fukuhara Japan
Elena Fernández Fernández Ireland
Chenglong Ge China
Aaron J. Sorrin United States
Eva Golunski relative to Susanne Koling Germany Susanne Koling's profile →
Citations per field
00.5×4.6×
Susanne Koling · 1×
Citations per year

Countries citing papers authored by Eva Golunski

Since Specialization
Citations

This map shows the geographic impact of Eva Golunski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Golunski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Golunski more than expected).

Fields of papers citing papers by Eva Golunski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Golunski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Golunski. The network helps show where Eva Golunski may publish in the future.

Co-authorship network of co-authors of Eva Golunski

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Golunski. A scholar is included among the top collaborators of Eva Golunski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Golunski. Eva Golunski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 12
2 3
3 20
4 5
5 1
6 5
7 51
8
Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
15
9 58
10 4
11 55
12 94
13
Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.
133
14 107
15 5

About Eva Golunski

Eva Golunski is a scholar working on Structural Biology, Pulmonary and Respiratory Medicine and Biomaterials, having authored 15 papers that have together received 568 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (5 papers), RNA Interference and Gene Delivery (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (71 citations), Pulmonary and Respiratory Medicine (227 citations) and Biomaterials (81 citations). Eva Golunski has collaborated with scholars based in United States. Frequent co-authors include J. Clifford Waldrep, Nadezhda V. Koshkina, Vernon Knight, Ronald Palacios, Jacqueline Samaridis, Ajay Kumar Gautam, Charles L. Densmore, Bo Xu, Brian E. Gilbert and Luz Roberts. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026